Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BONS.TA
- Price
- 16.60
- Stock movement up
- +- (%)
- Company name
- Bonus Biogroup
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Biotechnology
- Market cap
- 19.39B
- Ent value
- 19.40B
- Price/Sales
- -
- Price/Book
- 2208.41
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 1.10%
- 1 year return
- 0.61%
- 3 year return
- -36.26%
- 5 year return
- -14.30%
- 10 year return
- -3.78%
Last updated: 2025-04-16
DIVIDENDS
BONS.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 2208.41 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.17B |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -29.02M |
| Net income (TTM) | -29.47M |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 8.73M |
| Net receivables | 753.00K |
| Total current assets | 9.48M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 16.54M |
| Total assets | 26.41M |
| Accounts payable | 1.57M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 8.71M |
| Total liabilities | 17.63M |
| Shareholder's equity | 8.78M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -22.99M |
| Capital expenditures (TTM) | 420.00K |
| Free cash flow (TTM) | -23.41M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -335.68% |
| Return on Assets | -111.57% |
| Return on Invested Capital | -335.68% |
| Cash Return on Invested Capital | -266.61% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 16.90 |
| Daily high | 16.90 |
| Daily low | 16.60 |
| Daily Volume | 638K |
| All-time high | 71100.00 |
| 1y analyst estimate | - |
| Beta | 1.04 |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BONS.TA | S&P500 | |
| Current price drop from All-time high | -99.98% | -12.29% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 17 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -79.66% | -11.07% |
| Avg time to new high | 852 days | 12 days |
| Max time to new high | 4049 days | 1805 days |
COMPANY DETAILS
Marketcap
19.39B
Marketcap category
Large-cap
Description
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products in development include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications and is in Phase II clinical trial; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS and is in phase III trial. Its products in pipeline also comprise BonoFill for bone augmentation in osteoporosis patients; MesenCure for treating other inflammations and tissue damage; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is based in Haifa, Israel.
Employees
58
Website
Investor relations
-
SEC filings
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The Middle Eastern stock markets have recently experienced fluctuations, with Saudi Arabia's bourse breaking a three-day losing streak due to rising oil prices, highlighting the region's economic resi...
March 10, 2025
The Company is working to expand its indication to include patients who have respiratory distress from any cause, including acute respiratory distress syndrome (ARDS) MesenCure's market potential in a...
February 20, 2025
Global markets have experienced a turbulent period, with U.S. stocks mostly lower amid AI competition concerns and political tariff tensions, while European indices reached new highs following the ECB...
February 6, 2025
As global markets navigate a mixed landscape of rising stock indices and declining consumer confidence, investors are keenly watching for opportunities that align with current economic conditions. Pen...
January 2, 2025